Hepatitis C virus (HCV) la, lb, 2a, and 2b subtypes have been studied in 30 serum samples and in 20 paired liver biopsies from children with chronic hepatitis C. One serum sample was negative to the four HCV subtypes studied. HCV lb was detected alone in 53.3% (16130) of the serum samples; HCV la alone in 23.3% (7130) and a mixed infection in 20% (6130). In liver samples, HCV mixed infection was detected in a significantly higher proportion (50%: p < 0.05) than in serum, whereas HCV lb was detected alone in 35% (7120) and HCV l a alone in the remaining 15% (3120) Since identification of the HCV as the major causative agent of postransfusional non-A, non-B hepatitis (I), different HCV types and subtypes have been described (2). The development of PCR-based methods for HCV genotyping (3-5) has permitted the study of the prevalence of HCV types and subtypes in adult patients with chronic hepatitis C (3, 6). Most of these studies have shown that HCV type 1 is prevalent in European countries (7-9). The pathobiology of the different HCV types is, furthermore, currently under active investigation (10-12). However, all these studies have been based on the analysis of HCV types in serum, and, to our knowledge, there have been no reports concerning detection of HCV types in liver cells.
Hepatitis C virus (HCV) la, lb, 2a, and 2b subtypes have been studied in 30 serum samples and in 20 paired liver biopsies from children with chronic hepatitis C. One serum sample was negative to the four HCV subtypes studied. HCV lb was detected alone in 53.3% (16130) of the serum samples; HCV la alone in 23.3% (7130) and a mixed infection in 20% (6130). In liver samples, HCV mixed infection was detected in a significantly higher proportion (50%: p < 0.05) than in serum, whereas HCV lb was detected alone in 35% (7120) and HCV l a alone in the remaining 15% (3120) of liver samples. These results suggest that serum HCV genotyping may not reflect the viral population infecting the liver of a given patient. Additional studies should be performed concerning the pathobiology of hepatitis C virus with relation to the subtypes detected in liver. (Pediatr Res 38:
618-620, 1995)
Abbreviations HCV, hepatitis C virus PCR, polymerase chain reaction ALT, alanine aminotransferase RFLP, restriction fragment length polymorphism Since identification of the HCV as the major causative agent of postransfusional non-A, non-B hepatitis (I), different HCV types and subtypes have been described (2) . The development of PCR-based methods for HCV genotyping (3) (4) (5) has permitted the study of the prevalence of HCV types and subtypes in adult patients with chronic hepatitis C (3, 6) . Most of these studies have shown that HCV type 1 is prevalent in European countries (7) (8) (9) . The pathobiology of the different HCV types is, furthermore, currently under active investigation (10) (11) (12) . However, all these studies have been based on the analysis of HCV types in serum, and, to our knowledge, there have been no reports concerning detection of HCV types in liver cells.
In this study, we have determined the prevalence of HCV types 1 and 2 in serum and in liver samples from Spanish children with chronic hepatitis C.
METHODS
All 30 children included in this study (mean age: 10.1 + 4.5 y; range 2-17) had increased ALT levels for at least 6 mo previous to study entry; all had a chronic hepatitis histologically proven (24 chronic persistent hepatitis, 6 chronic active hepatitis), and all had serum HCV-RNA. Of these 30 children, 24 (80%) were anti-HCV positive. The suspected acquisition route of HCV infection was postransfusional in 21 cases (70%), parenteral injection in 4 (13%), and unknown in the remaining 5 (17%). Paired serum and frozen liver samples were available from 20 children. Written consent to perform the liver biopsies was obtained from the children's parents.
Anti-HCV was detected by ELISA I1 (Ortho Diagnostic System, Raritan, NJ) and confirmed by RIBA I1 (Ortho). Detection of serum HCV-RNA was carried out by nested PCR, using primers from the 5'-noncoding region, as previously described (13) . Total RNA from liver biopsies was obtained by using the RNAgents kit (Promega Corp., Madison, WI), following supplier instructions, and the amount of isolated total RNA was measured by spectrophotometry at 260 nm. HCV la, lb, 2a, and 2b subtypes were detected in serum and in 1 p g of total liver RNA, following the method described by Okamoto et al. (3) . The amplified products were visualized in an 8% polyacrylamide gel stained with ethidium bromide. Selected PCR products were directly cloned, using the TA Cloning kit (Invitrogen Corp., Sand Diego, CA), and clones were isolated and sequenced by the dideoxynucleotide chain termination reaction (Sequenase kit, U. S. Biochemical Corp., Cleveland, OH). Moreover, in an attempt to investigate the presence of HCV types 3, 4, 5, and 6, serum samples were also typed by RFLP analysis of the DNA amplified from the 5'-noncoding region of the HCV genome (5 
RESULTS
The RFLP analysis of serum samples showed that 29/30 children had HCV type 1, whereas the remaining child presented RFLP patterns that might be compatible with HCV types 1 and 2. In no case HCV types 3, 4, 5, and 6 were detected. By typing with primers derived from the core region, HCV l b was the subtype most frequently detected in serum samples (16130; 53.3%). HCV l a was found in seven children (23.3%), whereas another six patients (20%) presented a mixed HCV infection: five cases with HCV l a + l b and one with HCV l b + 2a (this latter child was also the one who presented RFLP patterns compatible with HCV types 1 and 2). HCV 2b was not detected, either alone, or in combination with another HCV genotype. Only one child proved negative for these four tested HCV subtypes, although he had HCV type 1 by RFLP analysis.
Mixed HCV infection was detected in the liver samples available from 20 patients, with significantly (p < 0.05) greater frequency than in serum (10/20,50% versus 6/30,20%, respectively). Thus, nine liver biopsies had HCV l a + lb, and one had HCV l b f 2a. HCV l b alone was detected in seven (35%) liver samples, whereas the other three (15%) liver biopsies had HCV l a alone. The specificity of mixed HCV infections (HCV l a + lb) was proven by the sequencing of PCR products obtained from the liver biopsies of the children (Fig. 1) . The comparison of results obtained in serum with those obtained in liver samples is shown in Table 1 . All HCV mixed infections detected in serum were confirmed in the liver. In contrast, several HCV infections detected in serum with one : c n : When ALT levels were compared with relation to HCV subtypes detected in liver samples, similar values were found between children with only one HCV subtype and those with mixed infection (105 2 61 versus 104 ? 121 IU/L, respectively). In addition, there was no relation between serum or liver HCV subtypes and the histologic diagnosis (data not shown).
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DISCUSSION
This study is the first to report the prevalence of HCV la, lb, 2a, and 2b subtypes in serum from children with chronic hepatitis C, in comparison with paired liver samples.
HCV l b was the subtype most frequently detected in serum from children, but a high proportion of mixed HCV infection has also been found. These results are in agreement with those which we previously reported in adult patients with chronic hepatitis C (9). The reason for the relatively high number of mixed HCV infection is unknown and requires further investigation.
When HCV typing was performed in the paired liver samples available, the presence of mixed HCV infection was not only confirmed but was, as well, significantly increased with respect to the percentage found in serum. In this context, six children with only one HCV subtype in serum had a double HCV infection in their liver cells. There are two possible explanations for this discrepancy: first, the HCV-RNA load may be higher in liver cells than in serum, permitting detection of the HCV subtype present at lower concentration in the hepatocytes; second, HCV genotyping in serum may reflect only those HCV types which are actively replicating in hepatocytes and are secreted to circulation, whereas, in liver cells, those other HCV types might also be detected in an inactive replication phase, or latent infection. Nevertheless, these hypotheses should be proven in future studies by the quantification of HCV-RNA, in both serum and liver samples, as well as by the detection in liver of the specific HCV-RNA negative strand of each subtype.
On the other hand, no significant relations were found among HCV subtypes (detected in serum and in liver) and ALT levels, or histologic diagnosis. This may be due to the relatively small number of children included in this study; therefore, further studies should be performed, increasing the number of serum and liver samples.
In summary, this study demonstrates that different results can be obtained on performing HCV typing in serum and in liver samples. Additional studies should be carried out concerning the pathobiology of HCV with relation to HCV subtypes detected in liver, as, to our knowledge, all published information relating to this matter has been exclusively based on serum HCV genotyping.
